Seeking Alpha

NPS Pharmaceuticals (NPSP 14.3%) pops today after it says the FDA has released the briefing...

NPS Pharmaceuticals (NPSP 14.3%) pops today after it says the FDA has released the briefing documents ahead of its October 16 Advisory Committee meeting for NPSP's experimental drug Gattex, which is being developed for the treatment of adults with short bowel syndrome. The overall comments appear to be positive, with no serious safety issues raised. The advisers also said access to the drug should not be restricted, nor will it require additional elements to assure it's safe use.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs